Google DeepMind releases AlphaGenome 2 model
Google DeepMind has unveiled the AlphaGenome 2 model, designed to predict how genetic variants impact gene expression within specific human cell types and states. The new model builds on data from more than 100 million single-cell profiles across 68 human tissues to support rare disease research and complex genetic traits.
DeepLife and 3Billion partner for genetic drug discovery
Parisian artificial intelligence company DeepLife and South Korean genomics firm 3Billion have announced a partnership to develop small-molecule treatments against new drug targets with a focus on genetic modifiers. The agreement integrates the TwinCell virtual cell platform with genomic data from more than 110,000 individuals.